BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35392142)

  • 21. The application value of CDFI and SMI combined with serological markers in distinguishing benign and malignant thyroid nodules.
    Li F; Sun W; Liu L; Meng Z; Su J
    Clin Transl Oncol; 2022 Nov; 24(11):2200-2209. PubMed ID: 35792982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The additive clinical value of 18F-FDG PET/CT in defining the recurrence of disease in patients with differentiated thyroid cancer who have isolated increased antithyroglobulin antibody levels.
    Ozkan E; Soydal C; Araz M; Aras G; Ibis E
    Clin Nucl Med; 2012 Aug; 37(8):755-8. PubMed ID: 22785502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.
    Hurteau JA; Woolas RP; Jacobs IJ; Oram DC; Kurman CC; Rubin LA; Nelson DL; Berchuck A; Bast RC; Mills GB
    Cancer; 1995 Nov; 76(9):1615-20. PubMed ID: 8635066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody.
    Nam HY; Paeng JC; Chung JK; Kang KW; Cheon GJ; Kim Y; Park DJ; Park YJ; Min HS; Lee DS
    Nuklearmedizin; 2014; 53(2):32-8. PubMed ID: 24276613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the diagnostic value of high frequency ultrasound and ultrasound-guided fine needle aspiration biopsy in papillary thyroid microcarcinoma].
    Qin J; Zhang S; Li G; Liu S; Shi X; Wu J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Aug; 35(8):718-723. PubMed ID: 34304533
    [No Abstract]   [Full Text] [Related]  

  • 26. Relationship between the absolute lymphocyte count/absolute monocyte count ratio, soluble interleukin 2 receptor level, serum programmed cell death 1 level, and the prognosis of patients with diffuse large B-cell lymphoma.
    Li C; Li W; Xu G; You M; Wu W; Kuang L
    Ann Palliat Med; 2021 Oct; 10(10):10938-10945. PubMed ID: 34763456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive Value of FNA-Tg and TgAb in Cervical Lymph Node Metastasis of Papillary Thyroid Carcinoma.
    Wu X; Liu Y; Li K; Yang Y; Lai P; Li J; Kou S
    Technol Cancer Res Treat; 2022; 21():15330338221127605. PubMed ID: 36128843
    [No Abstract]   [Full Text] [Related]  

  • 28. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
    Ozkan E; Aras G; Kucuk NO
    Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fine Needle Aspiration Cytology and Thyroglobulin Antibodies in Preoperative Diagnosis of Thyroid Malignancy.
    Hasukic B; Jakubovic-Cickusic A; Sehanovic E; Osmic H
    Med Arch; 2019 Dec; 73(6):382-385. PubMed ID: 32082004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B; Psenko V; Lipsey AL; Kaiser HE
    Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A predictive model of thyroid malignancy using clinical, biochemical and sonographic parameters for patients in a multi-center setting.
    Liu J; Zheng D; Li Q; Tang X; Luo Z; Yuan Z; Gao L; Zhao J
    BMC Endocr Disord; 2018 Mar; 18(1):17. PubMed ID: 29514621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Lymph Node Metastasis on Change of Positive Thyroglobulin Antibody in Differentiated Thyroid Carcinoma after Initial Treatment.
    Zhang T; Song LP; Zhao T; Gao W; Lin YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):539-543. PubMed ID: 28877833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET/CT.
    Seo JH; Lee SW; Ahn BC; Lee J
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):558-63. PubMed ID: 19744107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Predicting Role of Serum TSGF and sIL-2R for the Lymph Node Metastasis of Papillary Thyroid Carcinoma.
    Xu X; Wang W; Sun T; Tian B; Du L; Jing J
    Dis Markers; 2022; 2022():3730679. PubMed ID: 36092957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating epithelial cells as potential biomarkers for detection of recurrence in patients of papillary thyroid carcinoma with positive serum anti-thyroglobulin antibody.
    Li YR; Tseng CP; Hsu HL; Lin HC; Chen YA; Chen ST; Liou MJ; Lin JD
    Clin Chim Acta; 2018 Feb; 477():74-80. PubMed ID: 29229463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Identification of a subset at high risk of treatment failure.
    Stasi R; Zinzani L; Galieni P; Lauta VM; Damasio E; Dispensa E; Dammacco F; Tura S; Papa G
    Cancer; 1994 Sep; 74(6):1792-800. PubMed ID: 8082082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?
    Hosseini S; Payne RJ; Zawawi F; Mlynarek A; Hier MP; Tamilia M; Forest VI
    J Otolaryngol Head Neck Surg; 2016 May; 45(1):31. PubMed ID: 27179632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive Thyroid Peroxidase Antibody and Thyroglobulin Antibody are Associated With Better Clinicopathologic Features of Papillary Thyroid Cancer.
    Li L; Shan T; Sun X; Lv B; Chen B; Liu N; Zhang B; Hu S; Zeng Q; Turner AG; Sheng L
    Endocr Pract; 2021 Apr; 27(4):306-311. PubMed ID: 33645517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.